Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT

Yiftach Roth, Noam Barnea-Ygael, Lior Carmi, Eric A. Storch, Aron Tendler, Abraham Zangen

פרסום מחקרי: פרסום בכתב עתמאמרביקורת עמיתים

תקציר

OCD is a chronic and disabling disease with a lifetime prevalence of 2%-3%. About 40–60% of these patients do not adequately respond to pharmacotherapy and CBT. Deep transcranial magnetic stimulation (dTMS) was shown to be safe and effective as a treatment alternative for OCD and recently received regulatory approvals. Yet it is unclear whether patients who failed numerous medications and/or CBT can still benefit from dTMS. Here, we analyzed recent data from a double-blind multicenter dTMS study and found efficacy of this novel treatment even in OCD patient cohorts who previously failed to respond to multiple medications and CBT.

שפה מקוריתאנגלית אמריקאית
מספר המאמר113179
כתב עתPsychiatry Research
כרך290
מזהי עצם דיגיטלי (DOIs)
סטטוס פרסוםפורסם - 1 אוג׳ 2020

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2738???
  • ???subjectarea.asjc.2800.2803???

טביעת אצבע

להלן מוצגים תחומי המחקר של הפרסום 'Deep transcranial magnetic stimulation for obsessive-compulsive disorder is efficacious even in patients who failed multiple medications and CBT'. יחד הם יוצרים טביעת אצבע ייחודית.

פורמט ציטוט ביבליוגרפי